RESEARCH MONOGRAPH · KDC-MN-049

Choline Bitartrate

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

63/100

The cheap option that mostly doesnt reach the brain, useful for peripheral choline work

Choline bitartrate is the cheap workhorse choline salt and honestly thats both its strength and its problem. As a research tool for peripheral choline status, dietary choline restriction studies, or anywhere you need to raise plasma choline without worrying about central effects, its fine. As a cognitive supplement or central cholinergic precursor, the literature is genuinely thin.

The pharmacokinetics tell most of the story. Oral choline gets converted in significant amounts by gut bacteria to trimethylamine (TMA), which the liver oxidizes to TMAO, before any meaningful amount reaches the brain. Whats left after first-pass metabolism doesnt cross the BBB particularly efficiently because the choline transporter at the BBB is saturable. So the increase in central choline pools after oral choline bitartrate is modest at best, much smaller than what you'd get with alpha-GPC or citicoline at functionally similar doses.

The cognitive evidence reflects this. Most controlled studies comparing choline bitartrate to alpha-GPC or citicoline find the latter two compounds outperform on essentially every cognitive measure. The peripheral choline status improves with bitartrate, but the central effects are limited.

What we like: it's cheap, well-characterized as a molecule, and pharmacologically clean in the sense that you know exactly what you're getting (a quaternary ammonium salt of choline). For studies of dietary choline status, choline-deficient diet models, or peripheral cholinergic work, it does the job.

What we dont like: the marketing framing as a nootropic ignores the pharmacokinetic reality, the TMAO conversion creates a potential cardiovascular signal that the alpha-GPC and citicoline crowd dont fully escape but bitartrate makes the worst, and for central work the other choline sources are simply better.

Sourcing is trivial. Commodity ingredient, pharmacopoeia-grade material is widely available, multiple reputable suppliers, HPLC validation is straightforward. Storage is forgiving as long as you keep it dry.

Honestly, this is the choline source we'd use as a baseline comparator in cholinergic research rather than as the primary tool. Useful in its place. The place is just narrower than the supplement industry suggests.

Evidence: 50
Mechanism: 60
Reliability: 55
Safety: 70
Sourcing: 90
Value: 80
Signal: 35
Staying power: 60

Plain-language summary Intrigue 40 / 100

Choline bitartrate is a basic salt form of choline used as a dietary choline supplement. It is the cheapest form of supplemental choline but with lower bioavailability than alpha-GPC or CDP-choline for brain delivery. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Quaternary ammonium choline salt

A simple choline tartrate salt sold as a nutritional supplement; the bioavailability profile is limited compared with phospholipid-form choline precursors.

Abstract

Choline bitartrate is a 1:1 salt of choline and L-tartaric acid, sold widely as a dietary supplement at choline contents of 41 percent of the salt mass. The compound is the simplest and least expensive form of supplemental choline. Bioavailability is markedly lower than phospholipid-form choline precursors (alpha-GPC, citicoline, phosphatidylcholine): a substantial fraction of orally administered choline bitartrate is converted by gut bacteria to trimethylamine (which is hepatically oxidized to trimethylamine-N-oxide, TMAO) before reaching systemic circulation. This first-pass conversion reduces the systemically available choline and produces the characteristic "fishy" body odor reported with high research doses of choline bitartrate. Central choline elevation from oral choline bitartrate is correspondingly modest. The compound is appropriate for general dietary supplementation in subjects with low choline intake but is not the preferred form for cognitive enhancement applications, where alpha-GPC or citicoline produce more reliable central choline elevation per unit. Reported research dose ranges in the literature span 500 to 2000 mg of the salt (200 to 800 mg choline equivalent).

Mechanism of action

Direct choline source; substantial gut bacterial conversion to TMAO reduces systemic choline elevation.

Reported research dose ranges

Reported research dose ranges in the literature span 500 to 2000 mg of the salt.

References

Zeisel SH, da Costa KA. Choline: an essential nutrient for public health. Nutr Rev 2009.
Wang Z, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011.

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, reported research dose ranges, sourcing and quality verification, reconstitution and handling, stack interaction considerations, and a curated reference list. Available as a research-use-only PDF download.

KDC-MN-049

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Choline Bitartrate

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs